Verastem, Inc. (VSTM)
4.265
-0.10
(-2.18%)
USD |
NASDAQ |
May 27, 16:00
4.265
0.00 (0.00%)
After-Hours: 16:38
Verastem Free Cash Flow : -160.57M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Altimmune, Inc. | -71.67M |
| Ocugen, Inc. | -59.58M |
| BioXcel Therapeutics, Inc. | -57.38M |
| Xilio Therapeutics, Inc. | -57.36M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -52.12M |
| Cash from Investing (Quarterly) | -16.02M |
| Cash from Financing (Quarterly) | 28.69M |
| Free Cash Flow Per Share (Quarterly) | -0.5302 |
| Free Cash Flow to Equity (Quarterly) | -50.42M |
| Free Cash Flow to Firm (Quarterly) | -51.73M |
| Free Cash Flow Yield | -45.79% |